Eduardo Ekman Schenberg is an entrepreneur and a neuroscientist who works to bring radical and disruptive innovations in psychiatry, developing safer and better treatments than currently available, focusing on severe cases of drug addiction, depression, and trauma, among others. After more than ten years treading a solid academic trajectory in the interface between psychology, neuroscience, and psychiatry, Eduardo is now developing initiatives to provide new psychiatric treatments. He also studies the many facets of the amazonian medicine ayahuasca, bridging science and traditional knowledge and practices.
During his undergrad, Masters’s, and Ph.D. studies and post-doctoral research, Eduardo Schenberg specialized in psychoactive substances, studying their most varied effects – harmful as well as therapeutic – focusing on psychedelics (ayahuasca, LSD, ibogaine, MDMA, and psilocybin, among others). Eduardo led and participated in groundbreaking research revealing the neural basis of psychedelic effects in the human brain, helping to elucidate their effects in consciousness and also their promising therapeutic potentials. He has professional experiences within the sectors of government, business, and non-profits.
Notable Research Papers
- Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development (Schenberg, 2018)
- Neural correlates of the LSD experience revealed by multimodal neuroimaging (Carhart-Harris, Schenberg, et al., 2016)
- Acute biphasic effects of ayahuasca (Schenberg, et al., 2015)
- Treating drug dependence with the aid of ibogaine: A retrospective study (Schenberg, et al., 2014)
In our database you will also find him as an author on many more papers.
- Eduardo Schenberg: Bringing MDMA Assisted Psychotherapy to Brazil (Psychedelic Science, 2017)
- Physiological Effects of Ayahuasca on the Human Brain (AYA conference by ICEERS, 2014)
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)